P

Inventor

PINTO DONALD J P

US85 patents
⚠️ This page may combine multiple inventors who share the name “PINTO DONALD J P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

25 patents
US7115627B2Oct 3, 2006

Glycinamides as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO101 citations96
US6602895B2Aug 5, 2003

Inhibitors of factor Xa with a neutral P1 specificity group

BRISTOL MYERS SQUIBB CO80 citations96
US8367709B2Feb 5, 2013

Dipeptide analogs as coagulation factor inhibitors

BRISTOL MYERS SQUIBB CO42 citations94
US6407256B1Jun 18, 2002

Cyano-pyrrole, cyano-imidazole, cyano-pyrazole, and cyano-triazole compounds as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO23 citations93
US9453018B2Sep 27, 2016

Pyrimidinones as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO13 citations92
US7626039B2Dec 1, 2009

Arylpropionamide, arylacrylamide, ayrlpropynamide, or arylmethylurea analogs as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO14 citations92
US6599926B2Jul 29, 2003

Heteroaryl-phenyl substituted factor Xa inhibitors

BRISTOL MYERS SQUIBB CO37 citations92
US10487086B2Nov 26, 2019

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US10208068B2Feb 19, 2019

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9902742B2Feb 27, 2018

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9802939B2Oct 31, 2017

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations84
US9611274B2Apr 4, 2017

Macrocycles as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9192607B2Nov 24, 2015

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations84
US9108951B2Aug 18, 2015

Substituted 5,6,7,8-tetrahydro-1,6-naphthyridines as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO5 citations84
US9000172B2Apr 7, 2015

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations84
US7338963B2Mar 4, 2008

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO9 citations84
US7371761B2May 13, 2008

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO12 citations83
US7960411B2Jun 14, 2011

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO4 citations74
US7691846B2Apr 6, 2010

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO6 citations74
US7645799B2Jan 12, 2010

Substituted biaryl compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO7 citations74
US11136327B2Oct 5, 2021

Macrocycles as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO1 citations73
US9944625B2Apr 17, 2018

Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO3 citations73
US7235575B2Jun 26, 2007

Guanidine mimics as factor Xa inhibitors

BRISTOL MYERS SQUIBB CO4 citations73
US11053247B2Jul 6, 2021

Pyrimidinones as factor XIA inhibitors

BRISTOL MYERS SQUIBB CO2 citations72
US10336754B2Jul 2, 2019

Pyrimidinones as factor XIa inhibitors

BRISTOL MYERS SQUIBB CO2 citations72

BRISTOL MYERS SQUIBB PHARMA CO

12 patents
US6967208B2Nov 22, 2005

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO100 citations98
US6548525B2Apr 15, 2003

Nitrogen containing heteroaromatics with ortho-substituted P1's as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO125 citations96
US6989391B2Jan 24, 2006

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO59 citations95
US6500855B1Dec 31, 2002

Thrombin or factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO40 citations95
US6369227B1Apr 9, 2002

Thrombin or factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO44 citations95
US6995172B2Feb 7, 2006

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO19 citations93
US6436985B2Aug 20, 2002

Disubstituted pyrazolines and triazolines as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO21 citations93
US7005435B2Feb 28, 2006

Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO19 citations92
US6906070B2Jun 14, 2005

Guanidine mimics as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO13 citations92
US6602871B2Aug 5, 2003

Thrombin or factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO20 citations92
US6506771B2Jan 14, 2003

Heteroaryl-phenyl heterobicyclic factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO35 citations92
US6413980B1Jul 2, 2002

Nitrogen containing heterobicycles as factor Xa inhibitors

BRISTOL MYERS SQUIBB PHARMA CO41 citations92

DU PONT PHARM CO

4 patents

DU PONT MERCK PHARMA

3 patents

(unassigned)

3 patents

PINTO DONALD J P

1 patent

BRISTOL MEYERS SQUIBB CO

1 patent

CORTE JAMES R

1 patent

Showing the top 50 of 85 patents by PatentIndex Score.